HIGHLY EFFICIENT TRANSDUCTION OF THE GREEN FLUORESCENT PROTEIN GENE IN HUMAN UMBILICAL-CORD BLOOD STEM-CELLS CAPABLE OF COBBLESTONE FORMATION IN LONG-TERM CULTURES AND MULTILINEAGE ENGRAFTMENT OF IMMUNODEFICIENT MICE
Pb. Vanhennik et al., HIGHLY EFFICIENT TRANSDUCTION OF THE GREEN FLUORESCENT PROTEIN GENE IN HUMAN UMBILICAL-CORD BLOOD STEM-CELLS CAPABLE OF COBBLESTONE FORMATION IN LONG-TERM CULTURES AND MULTILINEAGE ENGRAFTMENT OF IMMUNODEFICIENT MICE, Blood, 92(11), 1998, pp. 4013-4022
Purified CD34(+) and CD34(+)CD38(-) human umbilical cord blood (uds) c
ells were transduced with the recombinant variant of Moloney murine le
ukemia virus (MoMLV) MFG-EGFP or with SF-EGFP. in which EGFP expressio
n is driven by a hybrid promoter of the spleen focus-forming virus (SF
FV) and the murine embryonic stem cell virus (MESV). Infectious MFG-EG
FP virus was produced by an amphotropic virus producer cell line (GP+e
nvAm12). SF-EGFP was produced in the PG13 cell line pseudotyped for th
e gibbon ape leukemia virus (GaLV) envelope proteins. Using a a-day gr
owth factor prestimulation, followed by a 2-day, fibronectin fragment
CH-296-supported transduction, CD34(+) and CD34(+)CD38(-) UCB subsets
were efficiently transduced using either vector. The use of the SF-EGF
P/PG13 retroviral packaging cell combination consistently resulted in
twofold higher levels of EGFP-expressing cells than the MFG-EGFP/Am12
combination. Transplantation of 10(5) input equivalent transduced CD34
(+) or 5 x 10(3) input equivalent CD34+CD38- UCB cells in nonobese dia
betic/severe combined immunodeficient (NOD/SCID) mice resulted in medi
an engraftment percentages of 8% and 5%, respectively, which showed th
at the in vivo repopulating ability of the cells had been retained. in
addition, mice engrafted after transplantation of transduced CD34(+)
cells using the MFG-EGFP/Am12 or the SF-EGFP/PG13 combination expresse
d EGFP with median values of 2% and 23% of human CD45(+) cells, respec
tively, which showed that the NOD/SCID repopulating cells were success
fully transduced. EGFP(+) cells were found in all human hematopoietic
lineages produced in NOD/SCID mice including human progenitors with in
vitro clonogenic ability. EGFP-expressing cells were also detected in
the human cobblestone area-forming cell (CAFC) assay at 2 to 6 weeks
of culture on the murine stromal cell line FBMD-1. During the transduc
tion procedure the absolute numbers of CAFC week 6 increased 5- to 10-
fold.,The transduction efficiency of this progenitor cell subset was s
imilar to the fraction of EGFP(+) human cells in the bone marrow of th
e NOD/SCID mice transplanted with MFG-EGFP/Am12 or SF-EGFP/PG13 transd
uced CD34+ cells, ie, 6% and 27%, respectively. The study thus shows t
hat purified CD34(+) and highly purified CD34(+)CD38(-) UCB cells can
be transduced efficiently with preservation of repopulating ability. T
he SF-EGFP/PG13 vector/packaging cell combination was much more effect
ive in transducing repopulating cells than the MFG-EGFP/Am12 combinati
on. (C) 1998 by The American Society of Hematology.